Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Stephen Rocamboli
AddedMar 31, 2024
UpdatedMay 31, 2026
Stephen Rocamboli

Stephen Rocamboli

Board Member, TFF Pharmaceuticals

CrunchbaseLinkedIn

Stephen Rocamboli's Career

TFF Pharmaceuticals
TFF Pharmaceuticals

Austin, TX, US

Board Member· Board
Esperion Therapeutics Esper
Esperion Therapeutics Esper

Ann Arbor, MI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Stephen Rocamboli's Career

TFF Pharmaceuticals
TFF Pharmaceuticals
Public$66.9M152018Austin, TX, US
Board Member· Board

Leadership at TFF Pharmaceuticals

Brandi L. RobertsBrandi L. RobertsBoard Member
Harlan WeismanHarlan WeismanBoard Member
Aaron FletcherAaron FletcherBoard Member
Robert S. MillsRobert S. MillsBoard Member

Similar to TFF Pharmaceuticals

Respira TherapeuticsRespira TherapeuticsAlbuquerque, NM, USDrug Delivery, Inhalationest. 2010Respira TherapeuticsAlbuquerque, NM, US · est. 2010

Respira: A drug delivery tech company specializing in efficient dry powder inhaler technologies.

Series B · $5.1M9
Transpire BioTranspire BioWeston, FL, USInhaled Medicinesest. 2022Transpire BioWeston, FL, US · est. 2022

Transire Bio: Innovating painless delivery of injectable drugs through inhaled medicine development.

Angel · $10k30
TBT PharmaTBT PharmaBaltimore, MD, USDermatology, Therapeuticsest. 2018TBT PharmaBaltimore, MD, US · est. 2018

TBT Pharma: A dermatology startup innovating with generic and off-patent compounds.

Seed · $700k9
Theron PharmaceuticalsTheron PharmaceuticalsSunnyvale, CA, USPharmaceuticalsest. 2008Theron PharmaceuticalsSunnyvale, CA, US · est. 2008

Theron Pharmaceuticals, a US-based biotech firm, develops long-acting treatments for chronic respiratory diseases.

Angel · $2.2M7
Esperion Therapeutics Esper
Esperion Therapeutics Esper
Public1992008Ann Arbor, MI, US
Board Member· Board

Leadership at Esperion Therapeutics Esper

Jay ShepardJay ShepardBoard Member
Mike PapeMike PapeFounder
Nicole VitulloNicole VitulloBoard Member
Sheldon KoenigSheldon KoenigBoard Member
J. Martin CarrollJ. Martin CarrollBoard Member
Dr Antonio M Gotto JrDr Antonio M Gotto JrBoard Member

Similar to Esperion Therapeutics Esper

Lipidio PharmaceuticalsLipidio PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2018Lipidio PharmaceuticalsSan Diego, CA, US · est. 2018

Lipidio Pharma: Advancing molecules for dermatological and metabolic diseases treatment.

Series A · $20M5
HDL TherapeuticsHDL TherapeuticsVero Beach, FL, USCardiovascular, Therapeuticsest. 2009HDL TherapeuticsVero Beach, FL, US · est. 2009

HDL Therapeutics: FDA-approved biotech firm specializing in cardiovascular disease treatment.

Public · $10.8M6
Elicio TherapeuticsElicio TherapeuticsCambridge, MA, USPharmaceuticalsest. 2011Elicio TherapeuticsCambridge, MA, US · est. 2011

Elicio: A pharmaceutical research firm dedicated to re-engineering immune responses to cancer.

Public · $222.3M38
Chesapeake TherapeuticsChesapeake TherapeuticsPikesville, MD, USMedicationsest. 2014Chesapeake TherapeuticsPikesville, MD, US · est. 2014

Chesapeake Therapeutics: Developing tailored medications for children's rheumatic diseases.

Pre-Seed · $1.3M5

Stephen Rocamboli's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Stephen Rocamboli

Stephen RemondiStephen RemondiCEO · Exa VenturesDendy YoungDendy YoungBoard Member · SecureGDan PiacquadioDan PiacquadioFounder · TherapeuticsStephen TurnerStephen TurnerBoard Member · Protea BiosciencesPaul OlivoPaul OlivoBoard Member · Aptimmune BiologicsStephen GillettStephen GillettBoard Member · Discord